secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001213900-23-019312
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam launches $15M public offering; reports positive trial results for portable 12-lead ECG
--------------------------------------------------------------------------------

- $15M public offering of common stock; proceeds for clinical/reg ($2M), R&D ($7M), sales/mkt ($1M), G&A ($5M).
- HIDES study: VECG sensitivity 93%, specificity 95% vs cardiologist 70%/83% for early MI detection.
- First 510(k) submission for recording device in Q1 2023; second for synthesized 12-lead in Q4 2023; clearances expected in 12 months.
- Credit-card-sized device can replicate 12-lead ECG; holds foundational patents in portable VECG.
- Management includes CEO Branislav Vajdic, CFO Rick Brounstein; advisor panel includes key cardiologists.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000121390023019312/0001213900-23-019312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000121390023019312/ea174926-8k_heartbeam.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-019312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer